Trial Profile
Abatacept Research Outcome as a First-line Biological Agent in the Real World.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Nov 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms ABROAD
- 01 Nov 2016 Results assessing predictive factors published in The Journal of Rheumatology (2016).
- 01 Sep 2016 Results assessing predictive factors published in The Journal of Rheumatology
- 12 Jan 2014 Status changed from recruiting to completed.